For the Inventor, By the Inventor

Enter assignee name

Menlo Park, CA, United States of America

Sangstat Medical Corporation

Calculating rank

USPTO Granted Patents = 34

% Expired Patents = 11.8

Forward Citations = 815

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Philippe J Pouletty (18 out of 26 patents)

Roland Buelow (13 out of 34 patents)

Suhasini Iyer (5 out of 5 patents)

4. Ralph E Levy (4 out of 5 patents)

5. Jacky Woo (4 out of 4 patents)

6. Moo J Cho (3 out of 4 patents)

7. Alexander R Lussow (3 out of 4 patents)

8. Chin-Hai Chang (3 out of 9 patents)

9. Peter Chun (2 out of 3 patents)

10. Beth Atwood (2 out of 2 patents)

11. Satya Dandekar (1 out of 2 patents)

12. Timothy C Fong (1 out of 6 patents)

13. Alexis E Te (1 out of 2 patents)

14. Jérôme Tiollier (1 out of 3 patents)

15. Laurent Sorlin (1 out of 1 patent)

Core Competencies:

Cytomodulating Peptides

Graft Survival

Immunoglobulin Infusion

HLA Typing

Autoimmune Disease

Bioactive Peptide Agents

Heme Oxygenase Activity

Combined Therapy

Liquid Medication Dispenser

Anti-alpha-gal Screening

Oral Cyclosporin Formulations

Soluble HLA Cross-Match

34 patents: Sort by Forward Citations

1. 7671026 - Cytomodulating peptides for treating interstitial cystitis (2010-03-02),

2. 7528240 - Method for producing human anti-thymocyte immunoglobulins (2009-05-05),

3. 7498309 - Pharmaceutical compositions for bioactive peptide agents (2009-03-03),

4. 7151090 - Methods for enhancing graft survival by modulating heme oxygenase activity (2006-12-19),

5. 7094413 - Combined therapy for treatment of HIV infection (2006-08-22),

6. 6982246 - Cytomodulating peptide for inhibiting lymphocyte activity (2006-01-03),

7. 6861414 - Methods for enhancing graft survival by modulating heme oxygenase activity (2005-03-01),

8. 6696545 - Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation (2004-02-24),

9. 6249717 - Liquid medication dispenser apparatus (2001-06-19),

10. 6162434 - Cytomodulating peptide for inhibiting lymphocyte activity (2000-12-19),

11. 6060467 - Graft survival prolongation with porphyrins (2000-05-09),

12. 6013641 - Use of hyaluronic acid as an immunosuppressant (2000-01-11),

13. 5962019 - Oral cyclosporin formulations (1999-10-05),

14. 5922548 - Anti .alpha.-gal screening technique (1999-07-13),

15. 5834017 - Oral cyclopsporin formulations (1998-11-10),

Company Overview

Sangstat Medical Corporation, based in Menlo Park, California, specializes in the development and manufacturing of innovative medical products, particularly in the field of transplantation and immunology. The company focuses on advancing therapies that enhance patient outcomes and improve the quality of life for individuals undergoing organ transplants. With a commitment to research and development, Sangstat is dedicated to addressing the complex challenges in transplant medicine through cutting-edge technology and scientific expertise.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

34 Patents

#46 in Menlo Park, CA

#2,382 in California

#10,042 in US

#19,697 in the World

Menlo Park, CA, United States of America

Sangstat Medical Corporation

Forward Citations = 815

30 inventors:

Philippe J Pouletty (18 out of 26 patents)

Roland Buelow (13 out of 34 patents)

Suhasini Iyer (5 out of 5 patents)

4. Ralph E Levy (4 out of 5 patents)

5. Jacky Woo (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sangstat Medical Corporation. Retrieved from https://idiyas.com/company/sangstat-medical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…